This study aims to protect software development by creating a Software Risk Assessment (SRA) model for each phase of the Software Development Life Cycle (SDLC) using an Adaptive Neuro-Fuzzy Inference System (ANFIS) model. Software developers discovered and validated the risk variables affecting each SDLC phase, following which relevant data about risk factors and associated SRA for each SDLC phase were collected. To create the SRA model for SDLC phases, risk factors were used as inputs, and SRA was used as an output. The formulated model was simulated using 70 % and 80 % of the data for training, while 30 % and 20 % were used for testing the model. The performance of the SRA models using the test datasets was evaluated based on accuracy. According to the study findings, many risk variables were discovered and confirmed for the requirement, design, implementation, integration, and operation phases of SDLC 11, 8, 9, 4, and 6, respectively. The SRA model was formulated using the risk factors using 2048, 256, 512, 16, and 64 inference rules for the requirement, design, implementation, integration, and operation phases, respectively. The study concluded that using the SRA model to assess security risk at each SDLC phase provided a secured software development process.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259873 | PMC |
http://dx.doi.org/10.1016/j.heliyon.2024.e33495 | DOI Listing |
J Cardiothorac Surg
January 2025
Department of Cardiothoracic Surgery, Aalborg University Hospital, Hobrovej 18-22, Aalborg, 9000, Denmark.
Background: The outcome of coronary artery bypass grafting (CABG) depends on several factors, including the quality of the distal anastomoses to the coronary arteries. Early graft failure may be caused by, e.g.
View Article and Find Full Text PDFHealth Res Policy Syst
January 2025
Department of Maternal and Child Health, University of North Carolina Chapel Hill School of Global Public Health, Chapel Hill, United States of America.
Background: Type 2 diabetes mellitus (T2D) remains a pressing public health concern. Despite advancements in antidiabetic medications, suboptimal medication adherence persists among many individuals with T2D, often due to the high cost of medications. To combat this issue, Blue Cross and Blue Shield of Louisiana (Blue Cross) introduced the $0 Drug Copay (ZDC) program, providing $0 copays for select drugs.
View Article and Find Full Text PDFInfect Dis Ther
January 2025
Clalit Community Division, Clalit Health Services, Tel Aviv, Israel.
Introduction: The effectiveness of AZD7442 (tixagevimab/cilgavimab) against COVID-19 hospitalizations was determined at 3 and 6 months among immunocompromised individuals in Israel during different variant circulations.
Methods: This was a retrospective cohort study using data from Clalit Health Services in Israel. Immunocompromised individuals eligible to receive AZD7442 300 mg between 15 February and 11 December 2022 were identified.
Sci Rep
January 2025
Department of Pharmacy, Affiliated Hospital of Southwest Jiao Tong University, The Third People's Hospital of Chengdu, Chengdu, 610014, China.
The pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear due to the complexity of its etiology. The emerging field of the epitranscriptome has shown significant promise in advancing the understanding of disease pathogenesis and developing new therapeutic approaches. Recent research has demonstrated that N4-acetylcytosine (ac4C), an RNA modification within the epitranscriptome, is implicated in progression of various diseases.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Obstetrics and Gynecology, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, 621000, Sichuan, China.
Objective Endometrial lesions are a frequent complication following breast cancer, and current diagnostic tools have limitations. This study aims to develop a machine learning-based nomogram model for predicting the early detection of endometrial lesions in patients. The model is designed to assess risk and facilitate individualized treatment strategies for premenopausal breast cancer patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!